{"SPADE_UN_12163": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_12163", "Peptide Name": "Qa (De Novo Synthesis)", "Source": "synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "IHKFWRRWFKHI", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=16μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=32μM);Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=16μM), Salmonella Pulloru C79-13(MIC=16μM)", "Hemolytic Activity": "[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.", "Cytotoxicity": "[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by Qa is 61.3%, 66.8%, 76.5%, 71.4%, 72.4%, 73.3%, 65.9% and 39.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "In PBS, the α-helix content of PQ is 2.89% and the β-strand content of that is 19.89%. In SDS, the α-helix content of PQ is 5.54% and the β-strand of that is 14.12%. In TFE, the α-helix content of PQ is 3.08% and the β-strand of that is 18.1%.", "Formula": "C88H124N26O13", "Mass": 1754.09, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.87, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.", "Literature": [{"Title": "Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability", "Pubmed ID": "30538681", "Reference": "Front Microbiol. 2018; 9 2832. Published online 2018 Nov 27. doi 10.3389/fmicb.2018.02832", "Author": "Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30538681"}, {"Title": "Short Symmetric-End Antimicrobial Peptides Centered on ?-Turn Amino Acids Unit Improve Selectivity and Stability", "Pubmed ID": "", "Author": "Dong n, Chou S, Li J, Xue C, Li X, Cheng B, Shan A, Xu L"}], "Frequent Amino Acids": "FHI", "Absent Amino Acids": "ACDEGLMNOPQSTUVY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_12160", "Similarity": 1.0, "Sequence": "IHKFWRCRRRFCRWFKHI"}, {"SPADE_ID": "SPADE_UN_12161", "Similarity": 1.0, "Sequence": "IHKFWRPGRWFKHI"}, {"SPADE_ID": "SPADE_UN_12162", "Similarity": 1.0, "Sequence": "IHKFWRGGRWFKHI"}]}}}